Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

114 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Spain's Tendam wants to launch IPO before February 2025, CEO says
RE
ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GL
ALX Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GL
Transcript : ALX Oncology Holdings Inc. Presents at UBS Biopharma Conference 2023, Nov-08-2023 01:30 PM
Spanish fashion chain Tendam considers going public, according to its president
RE
ALX Oncology Realigns Executive Leadership Team
GL
ALX Oncology Realigns Executive Leadership Team
AQ
ALX Oncology Holdings Inc. Appoints Jason Lettmann as Chief Executive Officer
CI
ALX Oncology Holdings Inc. Appoints Dr. Jaume Pons Transitions to Chief Scientific Officer
CI
ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update
GL
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
GL
ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights
AQ
Spain's Tendam sells its Russian stores to Belarusian company
RE
Spain's Tendam hands Russian shops to Belarusian company
RE
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
GL
ALX Oncology Announces Clinical Trial Collaboration with Sanofi to Evaluate Evorpacept in Combination with SARCLISA (isatuximab-irfc) in Patients with Multiple Myeloma
AQ
ALX Oncology : 2023 Proxy Statement
PU
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
GL
ALX Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
AQ
Meliá is studying the sale of some assets in the Caribbean to reduce its debt.
RE
Transcript : ALX Oncology Holdings Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 10:30 AM
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2023
GL
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
GL
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
AQ
Transcript : ALX Oncology Holdings Inc. - Special Call
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
GL
ALX Oncology Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
AQ
ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference
GL
ALX Oncology to Participate in the Cantor Oncology, Hematology & HemeOnc Conference
AQ
ALX Oncology : Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights - Form 8-K
PU
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
GL
ALX Oncology Reports Second Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
GL
Spanish fashion retailer Tendam to keep free returns, online/in-store sales mix
RE
ALX Oncology Announces Evorpacept Clinical Program Updates
GL
ALX Oncology Announces Evorpacept Clinical Program Updates
GL
ALX Oncology to Participate in the Jefferies 2022 Healthcare Conference
GL
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
GL
ALX Oncology Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights
AQ
ALX Oncology : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones - Form 8-K
PU
ALX Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Clinical Development and Operational Highlights and Upcoming Milestones
AQ
Transcript : ALX Oncology Holdings Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 10:30 AM
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022
GL
ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022
GL
ALX Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
ALX Oncology : Corporate Presentation
PU
ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights - Form 8-K
PU
ALX Oncology Corporate Presentation
PU
ALX Oncology Reports Third Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
GL
ALX Oncology SITC Conference Call Presentation
PU
Transcript : ALX Oncology Holdings Inc. - Special Call
No results for this search
  1. Stock Market
  2. Advanced search
  3. Jaume Pons
  4. News